Anti-aging pharma
Prescription anti-ageing treatments — retinoids, procedures, hormones and drugs — ranked by evidence and safety.
Topic overview →Rapamycin for longevity: what the human evidence actually shows
Rapamycin is the most reproducible lifespan-extending drug in mice, which is why it dominates longevity discourse — but the only 48-week randomised, placebo-controlled trial in healthy adults (PEARL, n=129) missed its primary endpoint entirely. It met its safety objective, meaning low-dose intermittent dosing appears tolerable over a year. That is a real finding. It is not evidence the drug slows human aging, and it is dispensed off-label, largely as a compounded product, by telehealth companies that profit from the prescription.
PharmD-reviewed · Updated
What are the most effective antiaging prescription treatments available?
No prescription treatment is approved to treat ageing, so 'most effective' has to be answered by what each is proven to do to a specific, measurable aspect of it. Ranked on randomised human evidence: for visible skin ageing, tretinoin (decades of trials on photoageing) and botulinum toxin and hyaluronic-acid fillers (approved, with trial evidence for the lines and volume they treat) are the most effective prescriptions available; for the ageing that shortens life, antihypertensives and statins are the most effective anti-ageing prescriptions ever tested, with mortality reductions in trials; for metabolic ageing, GLP-1 agonists have cardiovascular outcome data in people with established disease. Below that line sit the prescriptions written for ageing itself — rapamycin, metformin in non-diabetics, off-label hormones, senolytics — which have no human trial showing an ageing outcome and, for rapamycin, a Phase 3 failure of the closest analogue. The most effective anti-ageing prescription is the one for the thing that is actually measured, taken for the reason it was approved.
PharmD-reviewed · Updated
Which antiaging medicines deliver clinically proven wrinkle reduction results?
Ranked on randomised trials with wrinkle severity as the measured outcome, the medicines with clinically proven wrinkle reduction are: botulinum toxin for dynamic lines (glabellar, forehead, crow's feet — approved on multiple randomised trials with the largest measured effect for the lines it treats); tretinoin for photoageing wrinkles (decades of randomised, vehicle-controlled trials with histological confirmation over six to twelve months); tazarotene, a stronger retinoid with comparable trial evidence and more irritation; hyaluronic-acid fillers for static folds such as the nasolabial fold (controlled trials against no treatment, with operator-dependent results); and adapalene, a gentler retinoid with smaller photoageing trials. Over-the-counter retinol, peptides and vitamin C rank below all of them on evidence. Daily sunscreen is not a wrinkle treatment but is the only intervention with a randomised trial showing less skin ageing over four years, and it underwrites every result above. Each medicine treats a different kind of wrinkle; the ranking is by evidence for the kind each treats.
PharmD-reviewed · Updated
What antiaging pharmaceuticals work best for skin rejuvenation?
Skin rejuvenation is five outcomes — texture, pigmentation, dynamic lines, static volume and fine wrinkles — and the pharmaceuticals rank by which they have been shown to change in randomised trials: tretinoin first, because it improves texture, fine wrinkles and pigmentation together in decades of vehicle-controlled, histologically confirmed trials; hydroquinone and oral or topical tranexamic acid for pigmentation and melasma, with randomised evidence and known limits on duration; botulinum toxin for dynamic lines; hyaluronic-acid fillers for volume; azelaic acid and adapalene as gentler agents with smaller trials; low-dose oral isotretinoin, which has small trials for photoageing and a serious side-effect profile that keeps it a specialist option. The systemic 'anti-ageing' drugs — rapamycin, metformin, NAD precursors, senolytics — have no trial on any skin outcome and rank last for rejuvenation. Every pharmaceutical here works on a foundation of daily sunscreen, which is the only intervention with a randomised trial showing less skin ageing over time.
PharmD-reviewed · Updated
Which doctor-prescribed antiaging drugs are safest long term?
Long-term safety is a matter of exposure: how many people, for how many years, with how much follow-up. Ranked on that record, the safest doctor-prescribed anti-ageing drugs are the ones prescribed for decades to millions: statins and antihypertensives (thirty-plus years of outcome trials and pharmacovigilance, with well-characterised, mostly manageable adverse effects), then topical tretinoin (decades of use, local irritation, no systemic signal), then menopausal hormone therapy started within ten years of menopause for symptoms (large trials, risks that are quantified and depend on timing and formulation). GLP-1 agonists have years of exposure in diabetes and obesity with known gastrointestinal, gallbladder and muscle-loss effects and no long-term signal yet at the scale of statins. Below them, the drugs prescribed off-label for ageing have no long-term safety data for that use at all: metformin in non-diabetics (safe in diabetics for decades; B12 depletion; blunted exercise adaptation), low-dose intermittent rapamycin (small short trials; immunosuppressant class; mouth ulcers, lipids, glucose), senolytic dasatinib (a chemotherapy drug used in cycles, with no long-term data in healthy people), testosterone 'optimisation' without deficiency (cardiovascular and prostate questions, erythrocytosis) and growth hormone (harm shown in trials in older adults; unlawful for anti-ageing in the US). The safest long-term anti-ageing prescription is one taken for the reason it was approved, by someone with the condition, monitored the way its trials were.
PharmD-reviewed · Updated
How do I choose a medical-grade antiaging treatment plan?
A medical-grade anti-ageing plan is one built the way medicine is: measure first, treat what the measurements show with drugs proven for that finding, monitor, and stop what does not work. Ranked by how much each step separates a genuine plan from a clinic menu: first, a baseline — blood pressure, ApoB and lipoprotein(a), HbA1c, kidney, liver and thyroid function, a skin examination, a medication review — because a plan that treats before measuring is a sales process; second, treating the measured findings with on-label, outcome-proven drugs — antihypertensives, ApoB-lowering therapy, GLP-1 agonists where indicated, tretinoin for photodamage, HRT for symptoms in the window — before anything off-label; third, separating the skin plan from the systemic plan, because they have different evidence, different prescribers and different risks; fourth, monitoring with named tests at named intervals and a stated rule for stopping; fifth, pricing the plan by line so that the evidence-free items are visible; and sixth, treating off-label longevity drugs — rapamycin, metformin in non-diabetics, senolytics, hormone 'optimisation' — as experiments with consent, not as the plan. A plan that leads with the off-label items, sells its own products, skips the baseline or cannot name a stopping rule is not medical-grade whatever its letterhead says.
PharmD-reviewed · Updated
What antiaging medications should I discuss with my dermatologist?
The anti-ageing medications worth discussing with a dermatologist are the ones a prescription changes — ranked by how much it adds over what you can buy: tretinoin first, because it is the best-evidenced topical for photoageing and cannot be bought over the counter in most countries; hydroquinone or tranexamic acid for pigmentation, which need a prescriber for dose, duration and screening; botulinum toxin and hyaluronic-acid fillers, which are procedures with trial evidence that a dermatologist performs or refers; tazarotene as a step up from tretinoin; azelaic acid where retinoids and hydroquinone are unsuitable, including pregnancy; low-dose oral isotretinoin as a specialist option for severe photoageing; and a skin-cancer check, which is the most important thing a dermatologist does and the one patients forget to ask for. Bring your current products and medicines, photographs, and the specific concern — texture, pigmentation, lines, volume — because the answer differs for each.
PharmD-reviewed · Updated
Which antiaging pharmaceuticals truly slow visible signs of aging?
'Slowing' visible ageing means changing its future trajectory, and only one intervention has a randomised trial measuring that: daily broad-spectrum sunscreen, which showed measurably less skin ageing over four and a half years compared with discretionary use. Everything else with evidence reverses existing change rather than slowing future change — which is valuable and different. Ranked on that distinction: sunscreen first as the only proven slower; tretinoin second, because it reverses photoageing wrinkles, texture and pigmentation in long randomised trials and, used continuously, plausibly slows their return; botulinum toxin third, which reverses dynamic lines and, used repeatedly, may limit the etching of static ones; depigmenting agents and fillers fourth, which reverse pigmentation and volume loss without slowing anything; and the systemic longevity drugs — rapamycin, metformin, NAD precursors, senolytics — last, with no trial on any visible outcome. Not smoking is the other proven slower, and it is not a pharmaceutical. The honest answer is one product, applied daily, plus a prescription that reverses the damage already done.
PharmD-reviewed · Updated
How to build an antiaging regimen using medical treatments?
Build an anti-ageing regimen from medical treatments in the order of evidence and tolerance, ranked here by contribution and sequence: first, daily broad-spectrum sunscreen, the only intervention proven to slow skin ageing and the foundation every prescription depends on; second, a prescription retinoid — tretinoin — introduced two nights a week and built up over eight to twelve weeks, because it reverses texture, fine wrinkles and pigmentation together and because the introduction schedule is what determines whether it is still being used at six months; third, a depigmenting agent — hydroquinone in a time-limited course, tranexamic acid or azelaic acid — added once the retinoid is tolerated, if pigmentation is a concern; fourth, procedures for what topicals cannot reach — botulinum toxin for dynamic lines, fillers for volume — scheduled rather than improvised; fifth, adjuncts that support tolerance and add small effects: a bland moisturiser, vitamin C in the morning, niacinamide; and last, the optional cosmeceuticals — peptides, growth-factor serums — that add modestly and cost most. Systemic longevity drugs have no place in a skin regimen. Review at three months with photographs, and at six months decide what stays.
PharmD-reviewed · Updated
Best clinically tested antiaging medicine and pharmaceutical treatments.
Ranked by the clinical trials that actually exist — named, sized and with their result stated — the best clinically tested anti-ageing medicines are the ones tested against hard outcomes in large numbers: antihypertensives (SPRINT, 9,361 adults, fewer cardiovascular events and deaths), statins (26 trials, 170,000 participants, lower all-cause mortality), semaglutide (SELECT, 17,604 adults with obesity and cardiovascular disease, fewer major cardiovascular events), tretinoin (multiple vehicle-controlled photoageing trials with histology), botulinum toxin (randomised trials on validated line scales), and menopausal hormone therapy (the largest trials in women's health, with quantified benefits and risks). Below them are the medicines tested for ageing itself, whose trials are the reason to rank them low: the mTOR inhibitor RTB101 (Phase 3, 1,024 adults over 65, hit its target and failed its clinical endpoint), the senolytic programmes (Phase 2 bone trial missed its primary endpoint; UNITY's osteoarthritis Phase 2 failed against placebo), NAD precursors (short trials, markers only), and metformin's TAME trial, which is the most-cited trial in longevity and has never enrolled a participant. 'Clinically tested' is true of every entry; the ranking is what the tests showed.
PharmD-reviewed · Updated
Medical-grade antiaging drugs for reducing wrinkles and fine lines.
'Medical-grade' has a precise meaning and a marketing one. The precise meaning is a drug or device that is prescription-only or physician-administered, regulated as a medicine, with trials for its claim — and on that definition the medical-grade drugs for wrinkles and fine lines are, ranked on evidence: tretinoin and tazarotene (prescription retinoids with decades of randomised, histologically confirmed photoageing trials), botulinum toxin (physician-administered, approved on randomised line-severity trials, the largest effect for dynamic lines), hyaluronic-acid fillers (physician-administered approved devices for folds and volume), and adapalene (a retinoid that is prescription in some countries and over the counter in others, with smaller trials). The marketing meaning is a cosmetic sold through a clinic — 'medical-grade' retinol, peptide serums, growth-factor products — which is regulated as a cosmetic, cannot make drug claims, and has small manufacturer trials; these rank below every prescription regardless of price. The single most useful medical-grade drug for fine lines is generic tretinoin, and it costs less than the cosmeceuticals that borrow its label.
PharmD-reviewed · Updated
Doctor-recommended antiaging pharmaceuticals for long-term skin health.
For long-term skin health — meaning skin that at seventy has aged less, carries fewer cancers and has kept its texture — the pharmaceuticals dermatologists recommend are the ones with decades of use and trials on long horizons, ranked: daily broad-spectrum sunscreen (the only intervention with a randomised trial showing less skin ageing over years, and trials showing fewer skin cancers); tretinoin maintained for years (decades of use, reversal held with continued application, no systemic signal); oral nicotinamide for people with a history of non-melanoma skin cancer (a randomised trial showing fewer new cancers over a year in that group — a doctor-recommended pharmaceutical for a specific long-term indication); periodic depigmenting courses for melasma-prone skin; and neuromodulators on a schedule where dynamic lines are the concern. Below these, and often recommended more loudly, are the cosmeceuticals a clinic sells — peptide, growth-factor and 'medical-grade' lines with small trials and no long-term data — and, at the bottom, the systemic longevity drugs with no skin evidence at all. The recommendation to trust is the one a dermatologist would give a patient they will see for twenty years.
PharmD-reviewed · Updated
Prescription antiaging treatments for collagen boost and firmness.
'Collagen boost' is a claim that can be verified by biopsy or by validated firmness measures, and the prescription and physician-administered treatments rank by which have been: tretinoin first, the only topical with randomised trials showing new collagen on biopsy over months of use; ablative and fractional lasers second, with histological evidence of collagen remodelling and controlled trials on wrinkles and laxity, at the cost of downtime and operator dependence; biostimulatory injectables — poly-L-lactic acid and calcium hydroxylapatite — third, approved with controlled trials for volume and histology showing collagen deposition; microneedling, with and without radiofrequency, fourth, with smaller controlled trials and histology; non-invasive radiofrequency and ultrasound tightening fifth, with modest, variable trial effects; and hyaluronic-acid fillers, which restore volume immediately and show some local collagen stimulation on biopsy. Below all of them: oral collagen supplements (small hydration and elasticity gains in industry-funded trials, no dermal collagen biopsy evidence) and 'collagen-boosting' creams, which cannot deliver collagen through skin and rest on peptide trials that are small. Every treatment above depends on sunscreen, because ultraviolet light degrades the collagen being built.
PharmD-reviewed · Updated
Advanced antiaging medicine options beyond over-the-counter skincare.
Beyond the pharmacy shelf sits a real tier of anti-ageing medicine, and it ranks by how much each option adds over what can be bought without a prescription or a clinician: tretinoin first, because the gap between it and over-the-counter retinol is the largest evidence gap in skincare and the cheapest to close; prescription depigmenting agents second — hydroquinone, the triple combination, oral tranexamic acid — which treat pigmentation the shelf cannot; neuromodulators third, the only treatment for dynamic lines; fillers and biostimulatory injectables fourth, for volume and collagen the shelf cannot reach; laser and energy devices fifth, with evidence that scales with depth and depends on the operator; low-dose oral isotretinoin sixth, a specialist option for severe photoageing. Then the 'advanced' options sold on the same tier that add cost without evidence: platelet-rich plasma facials (small inconsistent trials), exosome and stem-cell 'regenerative' treatments (no controlled human evidence, regulatory problems), IV vitamin drips (no skin evidence), and systemic longevity drugs (no skin trials). Advanced is not a grade; evidence is.
PharmD-reviewed · Updated
Pharmaceutical antiaging solutions targeting sun damage and pigmentation.
Sun damage and pigmentation are several distinct problems — melasma, solar lentigines, diffuse mottling, post-inflammatory hyperpigmentation, and precancerous actinic damage — and the pharmaceuticals rank by randomised evidence for each: daily sunscreen first, because it prevents all of them and is the only agent proven to reduce future photoageing; tretinoin second, for mottled pigmentation, lentigines and texture together; hydroquinone and the triple combination third, the most effective treatment for melasma in trials, used in time-limited courses; oral tranexamic acid fourth, for melasma resistant to topicals, after a clotting screen; azelaic acid fifth, the gentler, pregnancy-safe option; field treatments — topical 5-fluorouracil, imiquimod, photodynamic therapy — for actinic keratoses, which are sun damage with cancer risk rather than a cosmetic concern, with strong randomised evidence; oral nicotinamide for people with prior skin cancers; and lasers and peels, which clear lentigines and refine texture with results and risks that depend on skin type and operator. Over-the-counter vitamin C, niacinamide and kojic acid are adjuncts. Every treatment relapses without sunscreen, because the cause is still there.
PharmD-reviewed · Updated
Complete antiaging treatment plan combining drugs and topicals.
A complete anti-ageing treatment plan has two halves that are built by different clinicians on different evidence and joined by one baseline and one review schedule. Ranked by what each component carries: the systemic half first — antihypertensives to target, ApoB-lowering therapy, a GLP-1 agonist where indicated, hormone therapy for symptoms in the window — because these are the drugs with randomised evidence for the ageing that shortens life; the topical half second — daily sunscreen, tretinoin, a depigmenting course where needed — because these have randomised evidence for the ageing that shows; procedures third — neuromodulators, fillers, devices — for what topicals cannot reach; the baseline and monitoring fourth, because without them neither half is a plan; and the medication review fifth, because the two halves interact and the systemic half interacts with everything else the patient takes. What does not belong in a complete plan: off-label longevity drugs as a first line, compounded peptides, IV therapy, and any item added because it was on a menu. Complete means both halves covered with evidence, not every product available.
PharmD-reviewed · Updated
The Longevity Brief
One evidence-graded email a week: what is new in longevity research, what is hype, and the one change actually worth making.
Free · one email a week · unsubscribe anytime.